BRONTE, Fabrizio
BRONTE, Fabrizio
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D.
2019-01-01 Lampertico P1, Brunetto MR2, Craxì Antonio, Gaeta GB4, Rizzetto M5, Rozzi A6, Colombo M7; Antonio D, Andreone P, Antonio D, Brancaccio G, Bronte F, Bruzzone L, Caccamo G, Caccianotti B, Calvaruso V, Chessa L, Ciarallo M, Coco B, Colombatto P, Cursaro C, D'Aluisio D, Demelia L, Di Marco V, Dissegna D, Invernizzi F, Lenisa I, Lembo T, Levrero M, Marchese V, Mangia G, Picciotto A, Pierconti S, Antonio D, Raimondo G, Rastelli C, Rizzo V, Santantonio T, Scuteri A, Sorbello O, Squadrito G, Subic M, Toniutto P, Vukotic R.
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors
2018-01-01 Bronte, Enrico*; Bronte, Giuseppe; Novo, Giuseppina; Rinaldi, Gaetana; Bronte, Fabrizio; Passiglia, Francesco; Russo, Antonio
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis
2015-01-01 Cabibi, D.; Bronte, F.; Porcasi, R.; Ingrao, S.; Giannone, A.; Maida, M.; Grazia Bavetta, M.; Petta, S.; Di Marco, V.; Calvaruso, V.
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.
2011-01-01 Rizzo, L; Calvaruso, V; Cacopardo, B; Alessi, N; Attanasio, M; Petta, S; Fatuzzo, F; Montineri, A; Mazzola, A; L'abbate, L; Nunnari, G; Bronte, F; Di Marco, V; Craxì, A; Cammà, C.
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy
2015-01-01 Bronte, G; Bronte, E; Novo, G; Pernice, G; Lo Vullo, F; Musso, E; Bronte, F; Gulotta, E; Rizzo, S; Rolfo, C; Silvestris, N; Bazan, V; Novo, S; Russo, A
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C
2012-01-01 Cammà, C; Petta, S; Enea, M; Bruno, R; Bronte, F; Capursi, V; Cicchetti, A; Colombo, GL; Di Marco, V; Gasbarrini, A; Craxì, A
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
2016-01-01 Di Marco, V.; D'Ambrosio, R.; Bronte, F.; Saracco, G.; Lanza, A.; Forni, G.; Poggiali, E.; Calvaruso, V.; Borsellino, G.; Cuccia, L.; Gerardi, C.; Maggio, A.; Madonia, S.; Fiorenza, F.; Salvo, A.; Caruso, V.; Russello, M.; Fidone, C.; Davã¬, A.; Squadrito, G.; Aulenti, G.; Filosa, A.; Cianciulli, P.; Lai, M.; Piga, A.; on behalf ITHACA (Italy for THAalassemia, ; Advances) Group, H.; Null,
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy
2009-01-01 Calvaruso, V; Cammà, C; Di Marco, V; Maimone, S; Bronte, F; Enea, M; Dardanoni, V; Manousou, P; Pleguezuelo, M; Xirouchakis, E; Attanasio, M; Dusheiko, G; Burroughs, AK; Craxì A
GENETIC, VIROLOGICAL AND CLINICAL FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPEMENT IN PATIENTS WITH CHRONIC HBV AND HCV INFECTION
Bronte, F.
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC
2013-01-01 Bronte, F.; Ferraro, D.; Calvaruso, V.; Pecoraro, G.; Sferrazza, S.; Augugliaro, M.; Destri, N.; Craxi, A.; DI MARCO, V.
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals
2018-01-01 Calvaruso, V.; Ferraro, D.; Licata, A.; Bavetta, M.; Petta, S.; Bronte, F.; Colomba, G.; Craxi, A.; DI MARCO, V.
HCV clearance among hemophiliacs and beta-thalassemics
2007-01-01 DI MARCO V; BRONTE F; SICILY GROUP FOR THE STUDY OF THALASSEMIA; CAPRA M; GERARDI; C; MAGGIO A; MALIZIA R; RIZZO M
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
2016-01-01 Bronte, F.; Bronte, G.; Fanale, D.; Caruso, S.; Bronte, E.; Bavetta, M.; Fiorentino, E.; Rolfo, C.; Bazan, V.; Marco, V.; Russo, A.
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.
2012-01-01 Di Marco, V; Bronte, F; Calvaruso, V; Capra, M; Borsellino, Z; Maggio, A; Renda, MC; Pitrolo, L; Lo Pinto, MC; Rizzo, M; Fiorenza, F; Gerardi, C; Grimaudo, S; Di Cristina, A; Levrero, M; Craxi, A
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis
2009-01-01 Petta, S; Cammà, C; DI Marco, V; Calvaruso, V; Enea, M; Bronte, F; Butera, G; Cabibi, D; Craxì, A.
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
2009-01-01 CAMMÀ C; PETTA S; DI MARCO V; BRONTE F; CIMINNISI S; LICATA G; PERALTA S; SIMONE F; MARCHESINI G; CRAXI' A
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience
2019-01-01 Calvaruso V.; Cacciola I.; Licata A.; Madonia S.; Benigno R.; Petta S.; Bronte F.; Conte E.; Malizia G.; Bertino G.; Distefano M.; Montineri A.; Digiacomo A.; Alaimo G.; Cacopardo B.; Davi A.; Guarneri L.; Scalisi I.; Colletti P.; Cartabellotta F.; Portelli V.; Prestileo T.; Averna A.; Iacobello C.; Mondello L.; Scifo G.; Russello M.; Squadrito G.; Raimondo G.; Camma C.; Craxi A.; Di Marco V.
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C
2008-01-01 DI MARCO V; CAPRA M; GAGLIARDOTTO F; BORSELLINO Z; CABIBI D; BARBARIA F; FERRARO D; CUCCIA L; RUFFO GB; BRONTE F; DI STEFANO R; ALMASIO PL; CRAXÌ A
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
2008-01-01 DI MARCO, V; CAPRA, M; GAGLIARDOTTO, F; BORSELLINO, Z; CABIBI, D; BARBARIA, F; FERRARO, D; CUCCIA, L; RUFFO, GB; BRONTE, F; DI STEFANO, R; ALMASIO, PL; CRAXI', A
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis
2011-01-01 Di Marco, V; Calvaruso, V; Iacò, A; Bronte, F; Biasi, L; Prestini, K; Sacchi, P; Amaddeo, G; Squadrito, G; Bruno, R; Puoti, M; Craxi, A
Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
---|---|---|---|---|---|
1-gen-2019 | Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. | Craxì AntonioBronte FCalvaruso VDi Marco V + | 01 - Contributo in rivista::1.01 Articolo in rivista | Lampertico P1, Brunetto MR2, Craxì Antonio, Gaeta GB4, Rizzetto M5, Rozzi A6, Colombo M7; Antonio D, Andreone P, Antonio D, Brancaccio G, Bronte F, Bruzzone L, Caccamo G, Caccianotti B, Calvaruso V, Chessa L, Ciarallo M, Coco B, Colombatto P, Cursaro C, D'Aluisio D, Demelia L, Di Marco V, Dissegna D, Invernizzi F, Lenisa I, Lembo T, Levrero M, Marchese V, Mangia G, Picciotto A, Pierconti S, Antonio D, Raimondo G, Rastelli C, Rizzo V, Santantonio T, Scuteri A, Sorbello O, Squadrito G, Subic M, Toniutto P, Vukotic R. | |
1-gen-2018 | Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors | Bronte, EnricoBronte, GiuseppeNovo, GiuseppinaBronte, FabrizioPassiglia, FrancescoRusso, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bronte, Enrico*; Bronte, Giuseppe; Novo, Giuseppina; Rinaldi, Gaetana; Bronte, Fabrizio; Passiglia, Francesco; Russo, Antonio | |
1-gen-2015 | Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis | CABIBI, DanielaBRONTE, FabrizioPORCASI, RossanaINGRAO, SabrinaGIANNONE, Antonino GiulioMAIDA, Marcello FabioPETTA, SalvatoreDI MARCO, VitoCALVARUSO, Vincenza + | 01 - Contributo in rivista::1.01 Articolo in rivista | Cabibi, D.; Bronte, F.; Porcasi, R.; Ingrao, S.; Giannone, A.; Maida, M.; Grazia Bavetta, M.; Petta, S.; Di Marco, V.; Calvaruso, V. | |
1-gen-2011 | Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. | CALVARUSO, VincenzaATTANASIO, MassimoPETTA, SalvatoreMAZZOLA, AlessandraBRONTE, FabrizioDI MARCO, VitoCRAXI, AntonioCAMMA', Calogero + | 01 - Contributo in rivista::1.01 Articolo in rivista | Rizzo, L; Calvaruso, V; Cacopardo, B; Alessi, N; Attanasio, M; Petta, S; Fatuzzo, F; Montineri, A; Mazzola, A; L'abbate, L; Nunnari, G; Bronte, F; Di Marco, V; Craxì, A; Cammà, C. | |
1-gen-2015 | Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy | BRONTE, GiuseppeBRONTE, EnricoNOVO, GiuseppinaBRONTE, FabrizioGULOTTA, ElianaRizzo, SBAZAN, VivianaNOVO, SalvatoreRUSSO, Antonio + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Bronte, G; Bronte, E; Novo, G; Pernice, G; Lo Vullo, F; Musso, E; Bronte, F; Gulotta, E; Rizzo, S; Rolfo, C; Silvestris, N; Bazan, V; Novo, S; Russo, A | |
1-gen-2012 | Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C | CAMMA', CalogeroPETTA, SalvatoreENEA, MarcoBRONTE, FabrizioCAPURSI, VincenzaDI MARCO, VitoCRAXI, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Cammà, C; Petta, S; Enea, M; Bruno, R; Bronte, F; Capursi, V; Cicchetti, A; Colombo, GL; Di Marco, V; Gasbarrini, A; Craxì, A | |
1-gen-2016 | Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? | Di Marco, VitoBronte, FabrizioCalvaruso, Vincenza + | 01 - Contributo in rivista::1.01 Articolo in rivista | Di Marco, V.; D'Ambrosio, R.; Bronte, F.; Saracco, G.; Lanza, A.; Forni, G.; Poggiali, E.; Calvaruso, V.; Borsellino, G.; Cuccia, L.; Gerardi, C.; Maggio, A.; Madonia, S.; Fiorenza, F.; Salvo, A.; Caruso, V.; Russello, M.; Fidone, C.; Davã¬, A.; Squadrito, G.; Aulenti, G.; Filosa, A.; Cianciulli, P.; Lai, M.; Piga, A.; on behalf ITHACA (Italy for THAalassemia, ; Advances) Group, H.; Null, | |
1-gen-2009 | Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy | CALVARUSO, VincenzaCAMMA', CalogeroDI MARCO, VitoBRONTE, FabrizioENEA, MarcoDARDANONI, ValentinoATTANASIO, MassimoCRAXI, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Calvaruso, V; Cammà, C; Di Marco, V; Maimone, S; Bronte, F; Enea, M; Dardanoni, V; Manousou, P; Pleguezuelo, M; Xirouchakis, E; Attanasio, M; Dusheiko, G; Burroughs, AK; Craxì A | |
- | GENETIC, VIROLOGICAL AND CLINICAL FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPEMENT IN PATIENTS WITH CHRONIC HBV AND HCV INFECTION | BRONTE, Fabrizio | 04 - Tesi di dottorato::4.2 Tesi di dottorato | Bronte, F. | |
1-gen-2013 | HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC | Bronte, FFerraro, DCalvaruso, VCraxi, ADi Marco, V. + | 01 - Contributo in rivista::1.13 Abstract in rivista | Bronte, F.; Ferraro, D.; Calvaruso, V.; Pecoraro, G.; Sferrazza, S.; Augugliaro, M.; Destri, N.; Craxi, A.; DI MARCO, V. | |
1-gen-2018 | HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals | Calvaruso, VFerraro, DLicata, ABavetta, M. GPetta, SBronte, FCOLOMBA, GiovannaCraxì, ADi Marco, V. | 01 - Contributo in rivista::1.01 Articolo in rivista | Calvaruso, V.; Ferraro, D.; Licata, A.; Bavetta, M.; Petta, S.; Bronte, F.; Colomba, G.; Craxi, A.; DI MARCO, V. | |
1-gen-2007 | HCV clearance among hemophiliacs and beta-thalassemics | DI MARCO, VitoBRONTE, FabrizioCAPRA, Massimo + | 01 - Contributo in rivista::1.13 Abstract in rivista | DI MARCO V; BRONTE F; SICILY GROUP FOR THE STUDY OF THALASSEMIA; CAPRA M; GERARDI; C; MAGGIO A; MALIZIA R; RIZZO M | |
1-gen-2016 | HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma | BRONTE, FabrizioBRONTE, GiuseppeFANALE, DanieleCARUSO, StefanoBRONTE, EnricoBAVETTA, Maria GraziaFIORENTINO, EugenioRolfo, Christian DiegoBAZAN, VivianaRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bronte, F.; Bronte, G.; Fanale, D.; Caruso, S.; Bronte, E.; Bavetta, M.; Fiorentino, E.; Rolfo, C.; Bazan, V.; Marco, V.; Russo, A. | |
1-gen-2012 | IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. | DI MARCO, VitoBRONTE, FabrizioCALVARUSO, VincenzaGRIMAUDO, StefaniaDI CRISTINA, AntoniettaCRAXI, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Di Marco, V; Bronte, F; Calvaruso, V; Capra, M; Borsellino, Z; Maggio, A; Renda, MC; Pitrolo, L; Lo Pinto, MC; Rizzo, M; Fiorenza, F; Gerardi, C; Grimaudo, S; Di Cristina, A; Levrero, M; Craxi, A | |
1-gen-2009 | Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis | PETTA, SalvatoreCAMMA', CalogeroDI MARCO, VitoCALVARUSO, VincenzaENEA, MarcoBRONTE, FabrizioBUTERA, GiuseppeCABIBI, DanielaCRAXI, Antonio | 01 - Contributo in rivista::1.01 Articolo in rivista | Petta, S; Cammà, C; DI Marco, V; Calvaruso, V; Enea, M; Bronte, F; Butera, G; Cabibi, D; Craxì, A. | |
1-gen-2009 | Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. | PETTA, SalvatoreDI MARCO, VitoBRONTE, FabrizioCIMINNISI, StefaniaCRAXI, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | CAMMÀ C; PETTA S; DI MARCO V; BRONTE F; CIMINNISI S; LICATA G; PERALTA S; SIMONE F; MARCHESINI G; CRAXI' A | |
1-gen-2019 | Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience | Calvaruso V.Licata A.Petta S.Bronte F.Conte E.Malizia G.Averna A.Mondello L.Camma C.Craxi A.Di Marco V. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Calvaruso V.; Cacciola I.; Licata A.; Madonia S.; Benigno R.; Petta S.; Bronte F.; Conte E.; Malizia G.; Bertino G.; Distefano M.; Montineri A.; Digiacomo A.; Alaimo G.; Cacopardo B.; Davi A.; Guarneri L.; Scalisi I.; Colletti P.; Cartabellotta F.; Portelli V.; Prestileo T.; Averna A.; Iacobello C.; Mondello L.; Scifo G.; Russello M.; Squadrito G.; Raimondo G.; Camma C.; Craxi A.; Di Marco V. | |
1-gen-2008 | Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C | DI MARCO, VitoCAPRA, MassimoCABIBI, DanielaBARBARIA, FrancescoFERRARO, DonatellaBRONTE, FabrizioALMASIO, Pier LuigiCRAXI, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | DI MARCO V; CAPRA M; GAGLIARDOTTO F; BORSELLINO Z; CABIBI D; BARBARIA F; FERRARO D; CUCCIA L; RUFFO GB; BRONTE F; DI STEFANO R; ALMASIO PL; CRAXÌ A | |
1-gen-2008 | Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. | DI MARCO, VitoCABIBI, DanielaFERRARO, DonatellaBRONTE, FabrizioDI STEFANO, RosaALMASIO, Pier LuigiCRAXI, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | DI MARCO, V; CAPRA, M; GAGLIARDOTTO, F; BORSELLINO, Z; CABIBI, D; BARBARIA, F; FERRARO, D; CUCCIA, L; RUFFO, GB; BRONTE, F; DI STEFANO, R; ALMASIO, PL; CRAXI', A | |
1-gen-2011 | Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis | DI MARCO, VitoCALVARUSO, VincenzaBRONTE, FabrizioCRAXI, Antonio + | 01 - Contributo in rivista::1.02 Recensione in rivista | Di Marco, V; Calvaruso, V; Iacò, A; Bronte, F; Biasi, L; Prestini, K; Sacchi, P; Amaddeo, G; Squadrito, G; Bruno, R; Puoti, M; Craxi, A |